40 results
8-K
EX-10.2
CTCX
Carmell Corp - Ordinary Shares
4 Apr 24
Carmell Announces $3.0 Million Private Placement
5:28pm
to each Holder, to conduct a reasonable investigation within the meaning of the Securities Act. The Company shall not file a Registration Statement … is aware. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such indemnified Person.
(b
8-K
EX-10.1
CTCX
Carmell Corp - Ordinary Shares
4 Apr 24
Carmell Announces $3.0 Million Private Placement
5:28pm
of Arcadia Securities, LLC.
EXHIBIT 10.1
“Proceeding” means an action, claim, suit, investigation or proceeding (including an informal investigation … . There has not been during the last ten (10) years, and to the knowledge of the Company, there is not pending or threatened in writing, any investigation
8-K
EX-10.1
CTCX
Carmell Corp - Ordinary Shares
25 Mar 24
Entry into a Material Definitive Agreement
8:46pm
such Litigation. The Company is not subject to any Order, and there is not any investigation pending or, to the Knowledge of the Company, threatened in which … or require in order to complete their due diligence investigation; and (iii) instruct its Representatives to cooperate with the Buyer and its
8-K
EX-99.1
48r1tzd1o cse26ic3
16 Jan 24
Carmell Corp Announces Addition of Dr. Sean Kelishadi to Scientific Advisory Board
7:14pm
8-K
EX-10.1
m7qr7crnoqlenjz
1 Aug 23
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
4:39pm
425
qsmxwawq
10 Jul 23
Business combination disclosure
8:03am
8-K
EX-10.1
2hwx2g
10 Jul 23
Entry into a Material Definitive Agreement
8:00am
424B3
r9lmki1 6n50
23 Jun 23
Prospectus supplement
4:47pm